Preoperative Nebulized Dexmedetomidine Versus Nebulized Magnesium Sulphate in Reducing Emergence Agitation in FESS
Condition(s) studied
Investigational drug(s) / intervention(s)
Dexmedetomidine: Patients in Group D will be nebulized with 1 μg/kg nebulized dexmedetomidine completed to 3 ml using normal saline 30 min before operation.The solution for nebulization will be administered by an anesthesiologist.
Magnesium sulfate: Patients in Group M will be nebulized with 250 mg nebulized magnesium sulphate completed to 3 ml using normal saline 30 min before operation . The solution for nebulization will be administered by an anesthesiologist.
Study summary
Emergence agitation after sinus surgery is a common postoperative complication characterized by confusion, disorientation, and potentially violent behavior as a patient wakes from general anesthesia.This study compare the effect of nebulized dexmedetomidine versus nebulized magnesium sulphate in reducing emergence agitation in adult undergoing functional endoscopic sinus surgery.
This study aims to compare preoperative nebulized dexmedetomidine and nebulized magnesium sulphate in reducing emergence agitation in adult undergoing functional endoscopic sinus surgery.
Eligibility
Primary outcome measure(s)
- The primary endpoint will Visual Analogue Scale (VAS)score after anesthesia — 30 minutes after operation in PACU
Pain will be assessed by VAS Score where 0 is no pain and 10 is the worst pain possible
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ain Shams University Hospitals | Cairo | Egypt |
More Ain Shams University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07677917 on ClinicalTrials.gov ↗ ← All trials in Egypt